
James William Rogers
Examiner (ID: 18141, Phone: (571)272-7838 , Office: P/1618 )
| Most Active Art Unit | 1618 |
| Art Unit(s) | 1618 |
| Total Applications | 1196 |
| Issued Applications | 505 |
| Pending Applications | 144 |
| Abandoned Applications | 587 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 17198483
[patent_doc_number] => 20210338577
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-11-04
[patent_title] => BIO-INSPIRED DEGRADABLE TOUGH ADHESIVES FOR DIVERSE WET SURFACES
[patent_app_type] => utility
[patent_app_number] => 17/283412
[patent_app_country] => US
[patent_app_date] => 2019-10-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14936
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -42
[patent_words_short_claim] => 39
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17283412
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/283412 | BIO-INSPIRED DEGRADABLE TOUGH ADHESIVES FOR DIVERSE WET SURFACES | Oct 10, 2019 | Abandoned |
Array
(
[id] => 17170332
[patent_doc_number] => 20210324002
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-10-21
[patent_title] => TERTIARY AMINO LIPIDATED CATIONIC PEPTIDES FOR NUCLEIC ACID DELIVERY
[patent_app_type] => utility
[patent_app_number] => 17/279508
[patent_app_country] => US
[patent_app_date] => 2019-09-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23680
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -22
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17279508
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/279508 | TERTIARY AMINO LIPIDATED CATIONIC PEPTIDES FOR NUCLEIC ACID DELIVERY | Sep 26, 2019 | Abandoned |
Array
(
[id] => 17198740
[patent_doc_number] => 20210338834
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-11-04
[patent_title] => DEGRADABLE HYALURONIC ACID HYDROGELS
[patent_app_type] => utility
[patent_app_number] => 17/280760
[patent_app_country] => US
[patent_app_date] => 2019-09-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 91857
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 457
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17280760
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/280760 | DEGRADABLE HYALURONIC ACID HYDROGELS | Sep 24, 2019 | Pending |
Array
(
[id] => 19011758
[patent_doc_number] => 11918659
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-03-05
[patent_title] => Materials and methods for inducing therapeutic hypothermia in a mammalian subject
[patent_app_type] => utility
[patent_app_number] => 17/277775
[patent_app_country] => US
[patent_app_date] => 2019-09-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 6612
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 74
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17277775
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/277775 | Materials and methods for inducing therapeutic hypothermia in a mammalian subject | Sep 18, 2019 | Issued |
Array
(
[id] => 19104634
[patent_doc_number] => 11957707
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-04-16
[patent_title] => Compositions and methods of use thereof
[patent_app_type] => utility
[patent_app_number] => 16/573559
[patent_app_country] => US
[patent_app_date] => 2019-09-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 45
[patent_figures_cnt] => 45
[patent_no_of_words] => 23346
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 123
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16573559
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/573559 | Compositions and methods of use thereof | Sep 16, 2019 | Issued |
Array
(
[id] => 15586131
[patent_doc_number] => 20200069600
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-03-05
[patent_title] => DELIVERY OF DRUG NANOPARTICLES AND METHODS OF USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/567164
[patent_app_country] => US
[patent_app_date] => 2019-09-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26689
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -26
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16567164
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/567164 | Delivery of drug nanoparticles and methods of use thereof | Sep 10, 2019 | Issued |
Array
(
[id] => 17368398
[patent_doc_number] => 20220023450
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-01-27
[patent_title] => BONE MARROW-, RETICULOENDOTHELIAL SYSTEM-, AND/OR LYMPH NODE-TARGETED RADIOLABELED LIPOSOMES AND METHODS OF THEIR DIAGNOSTIC AND THERAPEUTIC USE
[patent_app_type] => utility
[patent_app_number] => 17/274952
[patent_app_country] => US
[patent_app_date] => 2019-09-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17112
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -103
[patent_words_short_claim] => 38
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17274952
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/274952 | BONE MARROW-, RETICULOENDOTHELIAL SYSTEM-, AND/OR LYMPH NODE-TARGETED RADIOLABELED LIPOSOMES AND METHODS OF THEIR DIAGNOSTIC AND THERAPEUTIC USE | Sep 9, 2019 | Pending |
Array
(
[id] => 17168898
[patent_doc_number] => 20210322568
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-10-21
[patent_title] => Virucidal Nanoparticles And Use Thereof Against Influenza Virus
[patent_app_type] => utility
[patent_app_number] => 17/273113
[patent_app_country] => US
[patent_app_date] => 2019-09-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12307
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17273113
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/273113 | Virucidal Nanoparticles And Use Thereof Against Influenza Virus | Sep 2, 2019 | Abandoned |
Array
(
[id] => 15556709
[patent_doc_number] => 20200062766
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-02-27
[patent_title] => COELENTERAZINE ANALOGUES
[patent_app_type] => utility
[patent_app_number] => 16/548214
[patent_app_country] => US
[patent_app_date] => 2019-08-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21673
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -26
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16548214
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/548214 | Coelenterazine analogues | Aug 21, 2019 | Issued |
Array
(
[id] => 17227223
[patent_doc_number] => 20210353779
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-11-18
[patent_title] => GOLD NANOPARTICLE-LIGAND CONJUGATES AND METHODS OF USE
[patent_app_type] => utility
[patent_app_number] => 17/269113
[patent_app_country] => US
[patent_app_date] => 2019-08-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14368
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17269113
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/269113 | Gold nanoparticle-ligand conjugates and methods of use | Aug 19, 2019 | Issued |
Array
(
[id] => 15206493
[patent_doc_number] => 20190365933
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-12-05
[patent_title] => SOLVENT-FREE GADOLINIUM CONTRAST AGENTS
[patent_app_type] => utility
[patent_app_number] => 16/537906
[patent_app_country] => US
[patent_app_date] => 2019-08-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8709
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16537906
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/537906 | Solvent-free gadolinium contrast agents | Aug 11, 2019 | Issued |
Array
(
[id] => 20187131
[patent_doc_number] => 12398236
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-08-26
[patent_title] => Absorbable copolymers with improved thermal stability
[patent_app_type] => utility
[patent_app_number] => 16/536093
[patent_app_country] => US
[patent_app_date] => 2019-08-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 18
[patent_no_of_words] => 6732
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 137
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16536093
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/536093 | Absorbable copolymers with improved thermal stability | Aug 7, 2019 | Issued |
Array
(
[id] => 15114415
[patent_doc_number] => 20190343840
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-11-14
[patent_title] => RISPERIDONE SUSTAINED RELEASE MICROSPHERE COMPOSITION
[patent_app_type] => utility
[patent_app_number] => 16/525502
[patent_app_country] => US
[patent_app_date] => 2019-07-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7417
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 94
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16525502
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/525502 | Risperidone sustained release microsphere composition | Jul 28, 2019 | Issued |
Array
(
[id] => 16267445
[patent_doc_number] => 20200268932
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-08-27
[patent_title] => CROSSLINKABLE POLYMER COMPOSITIONS
[patent_app_type] => utility
[patent_app_number] => 16/523303
[patent_app_country] => US
[patent_app_date] => 2019-07-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10132
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16523303
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/523303 | CROSSLINKABLE POLYMER COMPOSITIONS | Jul 25, 2019 | Abandoned |
Array
(
[id] => 17154769
[patent_doc_number] => 20210315820
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-10-14
[patent_title] => LIPID NANOPARTICLE FORMULATIONS COMPRISING NUCLEIC ACID MIMICS
[patent_app_type] => utility
[patent_app_number] => 17/264133
[patent_app_country] => US
[patent_app_date] => 2019-07-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22987
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -134
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17264133
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/264133 | LIPID NANOPARTICLE FORMULATIONS COMPRISING NUCLEIC ACID MIMICS | Jul 24, 2019 | Abandoned |
Array
(
[id] => 17140256
[patent_doc_number] => 20210308267
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-10-07
[patent_title] => REJUVENATION OF CAR T CELL
[patent_app_type] => utility
[patent_app_number] => 17/266509
[patent_app_country] => US
[patent_app_date] => 2019-07-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8823
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -31
[patent_words_short_claim] => 114
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17266509
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/266509 | REJUVENATION OF CAR T CELL | Jul 20, 2019 | Abandoned |
Array
(
[id] => 15493031
[patent_doc_number] => 20200046704
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-02-13
[patent_title] => SUSTAINED RELEASE SMALL MOLECULE DRUG FORMULATION
[patent_app_type] => utility
[patent_app_number] => 16/511210
[patent_app_country] => US
[patent_app_date] => 2019-07-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5469
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 39
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16511210
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/511210 | Sustained release small molecule drug formulation | Jul 14, 2019 | Issued |
Array
(
[id] => 19104617
[patent_doc_number] => 11957690
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-04-16
[patent_title] => Chromogenic beta-lactamase substrate
[patent_app_type] => utility
[patent_app_number] => 17/260894
[patent_app_country] => US
[patent_app_date] => 2019-07-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 21
[patent_no_of_words] => 11027
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 69
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17260894
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/260894 | Chromogenic beta-lactamase substrate | Jul 14, 2019 | Issued |
Array
(
[id] => 15360805
[patent_doc_number] => 20200016167
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-01-16
[patent_title] => Methods for Treating Hyperbilirubinemia with Stannsoporfin
[patent_app_type] => utility
[patent_app_number] => 16/505295
[patent_app_country] => US
[patent_app_date] => 2019-07-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 33719
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16505295
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/505295 | Methods for Treating Hyperbilirubinemia with Stannsoporfin | Jul 7, 2019 | Abandoned |
Array
(
[id] => 15239515
[patent_doc_number] => 20190374543
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-12-12
[patent_title] => Therapeutic Combinations of an Antifolate and a BTK Inhibitor
[patent_app_type] => utility
[patent_app_number] => 16/502545
[patent_app_country] => US
[patent_app_date] => 2019-07-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 66152
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16502545
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/502545 | Therapeutic Combinations of an Antifolate and a BTK Inhibitor | Jul 2, 2019 | Abandoned |